Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-10 2022-03-24 156407
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160427
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2026-01-08 2026-01-09 275543
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-05 2024-06-07 224445
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-06-10 2021-09-30 140675
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-06-20 2025-02-06 230961
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-09 2020-08-27 119889
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160432
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-06-20 2025-01-30 230958
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215743
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-04-29 133770
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-09 2023-12-07 209672
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-07-11 2025-02-20 232747
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-02-17 2022-03-24 155137
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-16 2021-09-30 120473
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-27 2022-11-12 153709
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-27 2023-06-09 190728
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-05-27 133776
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-20 2025-03-27 250909
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-23 2025-03-04 248445
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CEFTRIAXONE SODIUM FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2025-05-28 2025-05-28 258691
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2025-05-27 2025-05-27 258359
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2021-02-12 2021-02-12 133886
CLOXACILLIN SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14018
CLOXACILLIN SODIUM FOR INJECTION 2G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14021
CLOXACILLIN SODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14014
COUGH SYRUP WITH CODEINE 30MG 3.3MG 100MG SYRUP SYRUP Reversed 2025-05-28 2025-06-03 258600
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344